Compared to the non-MetS group, individuals with MetS had significantly higher levels of systolic and diastolic blood pressure, triglycerides, total cholesterol, LDL-C, sdLDL-C, fasting glucose, insulin, and HOMA-IR (p < 0.001). This evidence concerns the gene INS and metabolic syndrome.